Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Younkin

Showing results (21-30 of 383) with videos related to

Pageof 39
Sort By:
Science (New York, N.Y.)|February 7, 1992
Processing of the amyloid protein precursor to potentially amyloidogenic derivativesT E Golde, S Estus, L H Younkin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2002
Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor proteinKiyoshi Niwa, Ken Kazama, Linda Younkin, et al.
The Journal of Biological Chemistry|September 29, 2004
Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic miceMatthew J Chiocco, Laura Shapiro Kulnane, Linda Younkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer diseaseM L Cohen, T E Golde, M F Usiak, et al.
Alzheimer Disease and Associated Disorders|September 10, 2002
Serum creatinine levels correlate with plasma amyloid Beta proteinZoe Arvanitakis, John A Lucas, Linda H Younkin, et al.
Brain Research|June 25, 1986
Effect of fibrillation on the secretion of acetylcholinesterase from cultured embryonic rat myotubesS K Brockman, S G Younkin
Current Alzheimer Research|June 25, 2005
Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic miceTina M Rees, Amit Berson, Ella H Sklan, et al.
Trends in Molecular Medicine|May 30, 2001
Presenilins as therapeutic targets for the treatment of Alzheimer's diseaseT E Golde, S G Younkin
Science (New York, N.Y.)|January 22, 2000
Neutral, single-component nickel (II) polyolefin catalysts that tolerate heteroatomsYounkin, Connor, Henderson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2001
Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's diseaseT Kawarabayashi, L H Younkin, T C Saido, et al.
Pageof 39

Showing results (21-30 of 383) with videos related to

Sort By:
Pageof 39
Science (New York, N.Y.)|February 7, 1992
Processing of the amyloid protein precursor to potentially amyloidogenic derivativesT E Golde, S Estus, L H Younkin, et al.
American Journal of Physiology. Heart and Circulatory Physiology|June 14, 2002
Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor proteinKiyoshi Niwa, Ken Kazama, Linda Younkin, et al.
The Journal of Biological Chemistry|September 29, 2004
Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic miceMatthew J Chiocco, Laura Shapiro Kulnane, Linda Younkin, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1988
In situ hybridization of nucleus basalis neurons shows increased beta-amyloid mRNA in Alzheimer diseaseM L Cohen, T E Golde, M F Usiak, et al.
Alzheimer Disease and Associated Disorders|September 10, 2002
Serum creatinine levels correlate with plasma amyloid Beta proteinZoe Arvanitakis, John A Lucas, Linda H Younkin, et al.
Brain Research|June 25, 1986
Effect of fibrillation on the secretion of acetylcholinesterase from cultured embryonic rat myotubesS K Brockman, S G Younkin
Current Alzheimer Research|June 25, 2005
Memory deficits correlating with acetylcholinesterase splice shift and amyloid burden in doubly transgenic miceTina M Rees, Amit Berson, Ella H Sklan, et al.
Trends in Molecular Medicine|May 30, 2001
Presenilins as therapeutic targets for the treatment of Alzheimer's diseaseT E Golde, S G Younkin
Science (New York, N.Y.)|January 22, 2000
Neutral, single-component nickel (II) polyolefin catalysts that tolerate heteroatomsYounkin, Connor, Henderson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|February 13, 2001
Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's diseaseT Kawarabayashi, L H Younkin, T C Saido, et al.
Pageof 39